Intentar ORO - Gratis
India's chip mission may swell to $20 bn
Mint New Delhi
|September 09, 2025
Meity proposes doubling in 2nd phase; Final nod likely by Dec

India's ambition to be a semiconductor superpower is poised to take a leap, with the Centre working on a $20 billion package to propel its chip and fab ecosystem.
The Union ministry of electronics and IT (Meity) has submitted the incentives proposal to the finance ministry, five people aware of the matter said, doubling the outlay for the first phase of the India Semiconductor Mission (ISM). Approval from the finance ministry is expected as early as October, after which the proposal will go to the Union Cabinet. The final clearance is likely before the close of 2025 when the first phase ends.
Meity is currently preparing a dossier that will outline the performance and returns of ISM's first phase, and compare them with similar schemes in other countries, three of the five people confirmed.
"The finance ministry had asked for an economic projection document from Meity, seeking an understanding of how ISM's first tranche's returns will play out, and how India's shaping up in comparison with other nations, especially the US, whose chip incentives are larger but market dynamics are undeniably trickier," one of the people cited above said.
The US Chips Act provides over $52 billion in subsidies and tax credits for the semiconductor sector, while the EU's Chips Act is mobilizing more than €43 billion in public and private investment.
Esta historia es de la edición September 09, 2025 de Mint New Delhi.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint New Delhi

Mint New Delhi
Andreessen Horowitz to open office in Bengaluru
Andreessen Horowitz, one of the world's biggest venture capital funds, is setting up an office in Bengaluru, multiple people familiar with the development said.
2 mins
October 10, 2025

Mint New Delhi
Silver ETFs fired up by scarcity, festivals
Silver exchange traded funds or ETFs opened Thursday with a record 10-12% premium to spot prices, underscoring a scramble for the metal as festive buying, industrial use, and investor FOMO (fear of missing out) drove up demand against tight supplies.
2 mins
October 10, 2025
Mint New Delhi
AI BROKE THE INFO BOTTLENECK, BUT VALUE INVESTING STILL DEPENDS ON INSIGHT
In a Bloomberg column, Guy Spier argues that AI has ended the golden age of value investing by removing the old information edge.
3 mins
October 10, 2025

Mint New Delhi
TCS preps big pivot to AI, data centres
At least $6 bn investment in 6 yrs; Q2 revenue beats expectations
3 mins
October 10, 2025
Mint New Delhi
Celebrating the snake in jewellery and art
An exhibition in Mumbai reiterates the power of the serpent motif in ornamentation and shines a light on Jaipur's wealth of gemstones
2 mins
October 10, 2025
Mint New Delhi
Akasa co-founder Khatri exits after ₹1,200 cr funding
Ex-IAF officer's departure is the first from the founding team since the carrier's 2022 launch.
1 mins
October 10, 2025

Mint New Delhi
Razorpay to enter four new markets in South-East Asia
Initial public offering (IPO)-bound fintech major Razorpay is planning to expand into three to four new South-East Asian markets by the end of 2026, the firm's top executive told Mint in an interaction.
1 mins
October 10, 2025

Mint New Delhi
Silver ETFs soar on festive demand, supply crunch
\"In the past three to four weeks, we have seen a surge in silver demand,\" said Vikram Dhawan, head of commodities and fund manager at Nippon India Mutual Fund, which runs the largest gold and silver ETFs in the country.
2 mins
October 10, 2025

Mint New Delhi
Govt, IBBI eye checks on shady pre-bankruptcy business deals
The Union government is looking to tighten the noose around shady transactions at companies undergoing bankruptcy proceedings committed by previous managements, two people aware of the plans said.
1 mins
October 10, 2025
Mint New Delhi
American chill pill
America's new 100% pharma tariff, going by a recent post online by US President Donald Trump, was aimed at \"branded or patented\" pharmaceutical products, barring those for which plants were being built in the US.
1 min
October 10, 2025
Listen
Translate
Change font size